Page last updated: 2024-08-24

nelfinavir and Elevated Cholesterol

nelfinavir has been researched along with Elevated Cholesterol in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheseaux, JJ; Darioli, R; Glauser, MP; Halfon, P; Marcovina, SM; Mooser, V; Nicod, P; PĂ©riard, D; Reymond, MJ; Sudre, P; Telenti, A1
Kessler, HA; Nerad, JL1
Allan, DA; Behrman, AJ1

Other Studies

3 other study(ies) available for nelfinavir and Elevated Cholesterol

ArticleYear
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.
    Circulation, 1999, Aug-17, Volume: 100, Issue:7

    Topics: Adult; Anti-HIV Agents; Arteriosclerosis; Child; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Indinavir; Lipids; Lipoprotein(a); Lipoproteins; Logistic Models; Male; Nelfinavir; Risk Factors; Ritonavir; Saquinavir; Thyrotropin

1999
Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jun-01, Volume: 32, Issue:11

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Interactions; Female; Health Personnel; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Indinavir; Lamivudine; Nelfinavir; Occupational Exposure; Reverse Transcriptase Inhibitors; Thyroxine; Zidovudine

2001
Lipid abnormalities in a healthcare worker receiving HIV prophylaxis.
    International journal of STD & AIDS, 2001, Volume: 12, Issue:8

    Topics: Adult; Allied Health Personnel; Anti-HIV Agents; Cholesterol; Cholesterol, LDL; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Lamivudine; Needlestick Injuries; Nelfinavir; Practice Guidelines as Topic; Renal Dialysis; Reverse Transcriptase Inhibitors; Zidovudine

2001